Catalyst Wire Dossier Catalyst Wire Dossier

PROMUS Element Stent

everolimus-eluting stent · Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PROMUS Element Stent, covering 2024-11-20 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent [NA]

See pricing